These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 10470620
1. [Arterial lipiodol chemoembolization of a left liver metastasis through the right internal thoracic artery]. Mignon F, Mesurolle B, Qanadli SD, Sissakian JF, Bruckert F, Barré O, Lacombe P. J Radiol; 1999 Aug; 80(8):872-4. PubMed ID: 10470620 [Abstract] [Full Text] [Related]
2. Transcatheter chemoembolization of progressive carcinoid liver metastasis. Therasse E, Breittmayer F, Roche A, De Baere T, Indushekar S, Ducreux M, Lasser P, Elias D, Rougier P. Radiology; 1993 Nov; 189(2):541-7. PubMed ID: 7692465 [Abstract] [Full Text] [Related]
3. Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients. Dumortier J, Chapuis F, Borson O, Davril B, Scoazec JY, Poncet G, Henry L, Boillot O, Mion F, Berger F, Partensky C, Paliard P, Valette PJ. Dig Liver Dis; 2006 Feb; 38(2):125-33. PubMed ID: 16389002 [Abstract] [Full Text] [Related]
4. Hepatocellular carcinoma with internal mammary artery supply: feasibility and efficacy of transarterial chemoembolization and factors affecting patient prognosis. Kim HC, Chung JW, Choi SH, Yoon JH, Lee HS, Jae HJ, Lee W, Park JH. J Vasc Interv Radiol; 2007 May; 18(5):611-9; quiz 620. PubMed ID: 17494842 [Abstract] [Full Text] [Related]
5. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, Yamaoka Y, Liver Cancer Study Group of Japan. Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600 [Abstract] [Full Text] [Related]
6. [Combined hepatic-artery and portal-vein chemoembolization for colorectal cancer metastatic to the liver]. Tarazov PG, Granov DA, Polikarpov AA, Polisalov VN, Borovik VV. Vopr Onkol; 2002 Aug; 48(1):83-7. PubMed ID: 12101575 [Abstract] [Full Text] [Related]
7. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma. Maeda S, Shibata J, Fujiyama S, Tanaka M, Noumaru S, Sato K, Tomita K. Hepatogastroenterology; 2003 Aug; 50(51):809-13. PubMed ID: 12828090 [Abstract] [Full Text] [Related]
8. [A case of liver metastasis of gastric leiomyosarcoma successfully treated by transarterial hepatic chemo-embolization and intra hepato-arterial chemotherapy repeated with infusion-a-port]. Miya A, Yasuda S, Morimoto O, Tsuji Y, Shiozaki K, Baba M, Ishida H, Masutani S, Tatsuta M, Kawasaki T, Satomi T. Gan To Kagaku Ryoho; 1997 Sep; 24(12):1878-81. PubMed ID: 9382556 [Abstract] [Full Text] [Related]
9. [Hepatic arterial infusion chemotherapy and embolization in the treatment of hepatic carcinoma]. Wang ZY, Shi ZH, Zai RY. Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):454-7. PubMed ID: 7720505 [Abstract] [Full Text] [Related]
10. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. Ruutiainen AT, Soulen MC, Tuite CM, Clark TW, Mondschein JI, Stavropoulos SW, Trerotola SO. J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443 [Abstract] [Full Text] [Related]
11. Transcatheter arterial embolization of the internal mammary artery in hepatocellular carcinoma. Kim JH, Chung JW, Han JK, Park JH, Choi BI, Han MC. J Vasc Interv Radiol; 1995 Jul; 6(1):71-4; discussion 75-7. PubMed ID: 7703585 [No Abstract] [Full Text] [Related]
12. Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: a non-randomized prospective study. Baur M, Walter R, Gebauer A, Tscholakoff D, Lochs H, Mühlbacher F, Turetschek K, Binder R, Hudec M, Gangl A, Ferenci P, Dittrich C. Int J Oncol; 2003 Sep; 23(3):811-9. PubMed ID: 12888922 [Abstract] [Full Text] [Related]
13. [The clinical efficacy of hepatic artery infusion chemotherapy and chemoembolization in the treatment of liver metastases]. Zeng X, Wang S, Wei C. Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):365-7. PubMed ID: 9387277 [Abstract] [Full Text] [Related]
14. [Lipiodol with and without Gelfoam in primary liver tumors. Plasma levels of Mitoxantrone and clinical results]. Civalleri D, Esposito M, De Caro G, Borgonovo G, De Cian F, Mondini G, Vannozzi O, Bocchio MM, Carrabetta S. G Chir; 1997 Sep; 18(6-7):362-7. PubMed ID: 9296600 [Abstract] [Full Text] [Related]
15. Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency. Geschwind JF, Ramsey DE, Cleffken B, van der Wal BC, Kobeiter H, Juluru K, Hartnell GG, Choti MA. Cardiovasc Intervent Radiol; 2003 Sep; 26(2):111-7. PubMed ID: 12616414 [Abstract] [Full Text] [Related]
16. Gelfoam powder embolization of the hepatic artery in liver metastases of carcinoid tumors. Lunderquist A, Ericsson M, Nobin A, Sandén G. Radiologe; 1982 Feb; 22(2):65-70. PubMed ID: 7071325 [Abstract] [Full Text] [Related]
17. [Hepatic chemoembolization for the treatment of carcinoid syndrome]. Kisilevzky N, dos Anjos LC, Carnevale F, de Souza CM, Mott Cde B, Laudana A, Magalhães AC. Rev Hosp Clin Fac Med Sao Paulo; 1995 Feb; 50(4):236-9. PubMed ID: 8560156 [Abstract] [Full Text] [Related]
18. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children. Li JP, Chu JP, Yang JY, Chen W, Wang Y, Huang YH. Cardiovasc Intervent Radiol; 2008 Feb; 31(6):1117-23. PubMed ID: 18560935 [Abstract] [Full Text] [Related]
19. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J. Hepatology; 2002 May; 35(5):1164-71. PubMed ID: 11981766 [Abstract] [Full Text] [Related]
20. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Gupta S, Johnson MM, Murthy R, Ahrar K, Wallace MJ, Madoff DC, McRae SE, Hicks ME, Rao S, Vauthey JN, Ajani JA, Yao JC. Cancer; 2005 Oct 15; 104(8):1590-602. PubMed ID: 16134179 [Abstract] [Full Text] [Related] Page: [Next] [New Search]